MEDP Financial Statements

Balance sheet, income statement, cash flow, and dividends for Medpace Holdings Inc (MEDP).


$10.33B Market Cap.

As of 02/11/2025 5:00 PM ET (MRY) • Disclaimer

MEDP Market Cap. (MRY)


MEDP Shares Outstanding (MRY)


MEDP Assets (MRY)


Total Assets

$2.10B

Total Liabilities

$1.28B

Total Investments

$0

MEDP Income (MRY)


Revenue

$2.11B

Net Income

$404.39M

Operating Expense

$209.44M

MEDP Cash Flow (MRY)


CF Operations

$608.82M

CF Investing

-$28.31M

CF Financing

-$154.01M

MEDP Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

MEDP Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$2,100,866,000 (26.80%)

$1,656,828,000 (22.50%)

$1,352,495,000 (-18.52%)

$1,659,935,000 (19.36%)

Assets Current

$1,029,229,000 (73.32%)

$593,828,000 (77.81%)

$333,962,000 (-51.66%)

$690,912,000 (45.87%)

Assets Non-Current

$1,071,637,000 (0.81%)

$1,063,000,000 (4.37%)

$1,018,533,000 (5.11%)

$969,023,000 (5.67%)

Goodwill & Intangible Assets

$696,762,000 (-0.21%)

$698,205,000 (-0.31%)

$700,404,000 (-0.48%)

$703,756,000 (-0.72%)

Shareholders Equity

$825,545,000 (47.70%)

$558,950,000 (44.66%)

$386,387,000 (-59.45%)

$952,928,000 (18.26%)

Property Plant & Equipment Net

$252,264,000 (-4.95%)

$265,390,000 (6.62%)

$248,917,000 (11.77%)

$222,711,000 (12.01%)

Cash & Equivalents

$669,436,000 (172.74%)

$245,449,000 (768.38%)

$28,265,000 (-93.87%)

$461,304,000 (66.08%)

Accumulated Other Comprehensive Income

-$14,743,000 (-46.38%)

-$10,072,000 (18.72%)

-$12,392,000 (-155.72%)

-$4,846,000 (-3599.24%)

Deferred Revenue

$710,585,000 (26.92%)

$559,860,000 (20.99%)

$462,729,000 (34.26%)

$344,641,000 (34.80%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$296,443,000 (-0.66%)

$298,400,000 (17.76%)

$253,404,000 (35.92%)

$186,432,000 (15.82%)

Trade & Non-Trade Payables

$32,528,000 (2.07%)

$31,869,000 (-3.63%)

$33,069,000 (28.78%)

$25,678,000 (-3.29%)

Accumulated Retained Earnings (Deficit)

$8,167,000 (103.68%)

-$221,645,000 (38.40%)

-$359,827,000 (-253.13%)

$234,984,000 (103.93%)

Tax Assets

$100,357,000 (34.83%)

$74,435,000 (54.81%)

$48,083,000 (91.31%)

$25,134,000 (4589.18%)

Tax Liabilities

$1,800,000 (-25.12%)

$2,404,000 (124.67%)

$1,070,000 (-0.93%)

$1,080,000 (-92.03%)

Total Debt

$126,234,000 (-11.18%)

$142,122,000 (-24.75%)

$188,867,000 (44.21%)

$130,965,000 (13.74%)

Debt Current

$0 (0%)

$0 (0%)

$50,000,000 (0%)

$0 (0%)

Debt Non-Current

$126,234,000 (-11.18%)

$142,122,000 (2.34%)

$138,867,000 (6.03%)

$130,965,000 (13.74%)

Total Liabilities

$1,275,321,000 (16.16%)

$1,097,878,000 (13.64%)

$966,108,000 (36.65%)

$707,007,000 (20.88%)

Liabilities Current

$1,104,553,000 (19.39%)

$925,131,000 (15.14%)

$803,470,000 (44.19%)

$557,217,000 (26.61%)

Liabilities Non-Current

$170,768,000 (-1.15%)

$172,747,000 (6.22%)

$162,638,000 (8.58%)

$149,790,000 (3.45%)

MEDP Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$2,109,054,000 (11.84%)

$1,885,842,000 (29.17%)

$1,459,996,000 (27.80%)

$1,142,377,000 (23.38%)

Cost of Revenue

$1,452,749,000 (6.71%)

$1,361,337,000 (32.48%)

$1,027,558,000 (26.20%)

$814,222,000 (25.81%)

Selling General & Administrative Expense

$180,184,000 (11.67%)

$161,352,000 (22.79%)

$131,400,000 (21.19%)

$108,421,000 (17.65%)

Research & Development Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Expenses

$209,435,000 (11.59%)

$187,680,000 (22.08%)

$153,741,000 (18.68%)

$129,540,000 (15.99%)

Interest Expense

-$24,996,000 (-5222.13%)

$488,000 (-83.20%)

$2,905,000 (2666.67%)

$105,000 (134.20%)

Income Tax Expense

$71,536,000 (35.30%)

$52,872,000 (41.02%)

$37,492,000 (87.42%)

$20,004,000 (-13.58%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$404,386,000 (42.99%)

$282,810,000 (15.26%)

$245,368,000 (34.93%)

$181,848,000 (25.08%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$404,386,000 (42.99%)

$282,810,000 (15.26%)

$245,368,000 (34.93%)

$181,848,000 (25.08%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$404,386,000 (42.99%)

$282,810,000 (15.26%)

$245,368,000 (34.93%)

$181,848,000 (25.08%)

Weighted Average Shares

$30,957,000 (0.76%)

$30,722,000 (-5.14%)

$32,388,000 (-9.69%)

$35,862,000 (0.64%)

Weighted Average Shares Diluted

$32,014,000 (0.54%)

$31,841,000 (-5.43%)

$33,671,000 (-10.68%)

$37,697,000 (-0.03%)

Earning Before Interest & Taxes (EBIT)

$450,926,000 (34.14%)

$336,170,000 (17.64%)

$285,765,000 (41.50%)

$201,957,000 (20.05%)

Gross Profit

$656,305,000 (25.13%)

$524,505,000 (21.29%)

$432,438,000 (31.78%)

$328,155,000 (17.73%)

Operating Income

$446,870,000 (32.67%)

$336,825,000 (20.86%)

$278,697,000 (40.32%)

$198,615,000 (18.90%)

MEDP Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$28,308,000 (18.25%)

-$34,629,000 (10.62%)

-$38,742,000 (-23.52%)

-$31,364,000 (-0.48%)

Net Cash Flow from Financing

-$154,009,000 (15.68%)

-$182,642,000 (76.46%)

-$775,775,000 (-1645.16%)

-$44,453,000 (45.97%)

Net Cash Flow from Operations

$608,815,000 (40.48%)

$433,374,000 (11.68%)

$388,050,000 (47.36%)

$263,327,000 (1.80%)

Net Cash Flow / Change in Cash & Cash Equivalents

$423,987,000 (95.22%)

$217,184,000 (150.15%)

-$433,039,000 (-335.94%)

$183,538,000 (25.84%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$36,548,000 (0.27%)

-$36,648,000 (0.63%)

-$36,879,000 (-30.45%)

-$28,271,000 (9.79%)

Issuance (Repayment) of Debt Securities

$0 (0%)

-$50,000,000 (-200.00%)

$50,000,000 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

-$154,009,000 (-16.11%)

-$132,642,000 (83.94%)

-$825,775,000 (-1757.64%)

-$44,453,000 (45.97%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$2,511,000 (-332.28%)

$1,081,000 (116.45%)

-$6,572,000 (-65.46%)

-$3,972,000 (-696.40%)

Share Based Compensation

$25,514,000 (24.36%)

$20,516,000 (-4.18%)

$21,412,000 (47.99%)

$14,469,000 (4.97%)

Depreciation Amortization & Accretion

$52,375,000 (13.92%)

$45,974,000 (13.92%)

$40,356,000 (7.88%)

$37,407,000 (11.82%)

MEDP Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

31.10% (11.87%)

27.80% (-6.08%)

29.60% (3.14%)

28.70% (-4.65%)

Profit Margin

19.20% (28.00%)

15.00% (-10.71%)

16.80% (5.66%)

15.90% (1.27%)

EBITDA Margin

23.90% (17.73%)

20.30% (-8.97%)

22.30% (6.19%)

21.00% (-3.67%)

Return on Average Equity (ROAE)

51.50% (-19.53%)

64.00% (5.96%)

60.40% (196.08%)

20.40% (7.37%)

Return on Average Assets (ROAA)

20.50% (7.89%)

19.00% (3.26%)

18.40% (55.93%)

11.80% (2.61%)

Return on Sales (ROS)

21.40% (20.22%)

17.80% (-9.18%)

19.60% (10.73%)

17.70% (-2.75%)

Return on Invested Capital (ROIC)

-255.50% (91.00%)

-2839.30% (-747.65%)

438.40% (60.47%)

273.20% (31.73%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

25.44 (-23.65%)

33.32 (18.74%)

28.06 (-34.76%)

43.01 (25.76%)

Price to Sales Ratio (P/S)

4.88 (-2.34%)

4.99 (5.98%)

4.71 (-31.03%)

6.83 (27.53%)

Price to Book Ratio (P/B)

12.51 (-25.67%)

16.83 (-1.58%)

17.1 (108.30%)

8.21 (32.82%)

Debt to Equity Ratio (D/E)

1.54 (-21.33%)

1.96 (-21.44%)

2.5 (236.93%)

0.74 (2.20%)

Earnings Per Share (EPS)

13.06 (41.96%)

9.2 (21.53%)

7.57 (49.60%)

5.06 (24.32%)

Sales Per Share (SPS)

68.13 (10.99%)

61.38 (36.17%)

45.08 (41.51%)

31.86 (22.59%)

Free Cash Flow Per Share (FCFPS)

18.49 (43.16%)

12.91 (19.09%)

10.84 (65.44%)

6.55 (2.73%)

Book Value Per Share (BVPS)

26.67 (46.57%)

18.19 (52.51%)

11.93 (-55.10%)

26.57 (17.51%)

Tangible Assets Book Value Per Share (TABVPS)

45.36 (45.36%)

31.2 (54.98%)

20.13 (-24.49%)

26.66 (39.36%)

Enterprise Value Over EBIT (EV/EBIT)

22 (-21.43%)

28 (16.67%)

24 (-35.14%)

37 (27.59%)

Enterprise Value Over EBITDA (EV/EBITDA)

19.47 (-21.30%)

24.74 (17.71%)

21.02 (-33.39%)

31.55 (30.63%)

Asset Turnover

1.07 (-15.84%)

1.27 (16.10%)

1.09 (47.30%)

0.74 (1.09%)

Current Ratio

0.93 (45.17%)

0.64 (54.33%)

0.42 (-66.45%)

1.24 (15.24%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$572,267,000 (44.25%)

$396,726,000 (12.97%)

$351,171,000 (49.40%)

$235,056,000 (3.40%)

Enterprise Value (EV)

$9,797,617,300 (3.64%)

$9,453,225,637 (37.93%)

$6,853,825,122 (-9.24%)

$7,551,629,529 (55.04%)

Earnings Before Tax (EBT)

$475,922,000 (41.78%)

$335,682,000 (18.67%)

$282,860,000 (40.13%)

$201,852,000 (19.77%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$503,301,000 (31.70%)

$382,144,000 (17.18%)

$326,121,000 (36.24%)

$239,364,000 (18.69%)

Invested Capital

-$243,651,000 (-248.90%)

-$69,835,000 (-857.18%)

$9,223,000 (-86.56%)

$68,623,000 (-13.22%)

Working Capital

-$75,324,000 (77.26%)

-$331,303,000 (29.44%)

-$469,508,000 (-451.18%)

$133,695,000 (298.60%)

Tangible Asset Value

$1,404,104,000 (46.47%)

$958,623,000 (47.01%)

$652,091,000 (-31.80%)

$956,179,000 (40.24%)

Market Capitalization

$10,326,240,300 (9.79%)

$9,405,393,637 (42.38%)

$6,605,929,122 (-15.54%)

$7,821,805,529 (57.08%)

Average Equity

$785,531,250 (77.70%)

$442,046,000 (8.84%)

$406,135,000 (-54.39%)

$890,455,500 (16.66%)

Average Assets

$1,975,191,000 (32.87%)

$1,486,552,500 (11.34%)

$1,335,179,750 (-13.27%)

$1,539,536,500 (22.03%)

Invested Capital Average

-$176,466,250 (-1390.46%)

-$11,839,750 (-118.16%)

$65,188,750 (-11.83%)

$73,932,750 (-8.84%)

Shares

31,081,601 (1.30%)

30,683,436 (-1.34%)

31,099,897 (-13.47%)

35,939,191 (0.47%)